Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States Government”

27 pharma patents match "The United States Government" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 27
Index total 30,257
Page 1 / 2

Quick answer

This filtered view shows 27 pharmaceutical patents matching "The United States Government" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

27 results for “The United States Government” · 30,257 patents in full index Clear search

  1. US 12233087

    Palladium hyaluronic acid particles and methods of managing cancer or angiogenic conditions

    The United States Government represented byt The United States Department of Veterans Affairs · Granted Feb 25, 2025 · Expires Feb 20, 2045

    granted

  2. US 12162818

    Inhibitors of the n-terminal domain of the androgen receptor

    The United States Government represented by the Department of Veterans Affairs · Granted Dec 10, 2024 · Expires Dec 5, 2044

    granted

  3. US 12144788

    Visual cycle modulators

    The United States Government as Represented by The Department of Veteran Affairs · Granted Nov 19, 2024 · Expires Nov 14, 2044

    granted

  4. US 12049486

    PAC1 receptor agonists (MAXCAPs) and uses thereof

    The United States Government represented by the Department of Veterans Affairs · Granted Jul 30, 2024 · Expires Jul 25, 2044

    granted

  5. US 11951152

    Microparticle compositions for controlled delivery of telmisartan and actinomycin D

    The United States Government as Represented by The Department of Veteran Affairs · Granted Apr 9, 2024 · Expires Apr 4, 2044

    granted

  6. US 11806389

    Compositions and methods for treating central nervous system injury

    The United States Government as Represented by The Department of Veteran Affairs · Granted Nov 7, 2023 · Expires Nov 2, 2043

    granted

  7. US 11752220

    Method of delivering genes and drugs to a posterior segment of an eye

    The United States Government as Represented by the Department of Veterans Affair · Granted Sep 12, 2023 · Expires Sep 7, 2043

    granted

  8. US 11730799

    Cancer vaccines and methods of producing and using same

    THE UNITED STATES GOVERNMENT DEPARTMENT OF VETERANS AFFAIRS · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  9. US 11680079

    Nucleic acid aptamers to treat histone-induced disease states

    The United States Government as Represented by The Department of Veteran Affairs · Granted Jun 20, 2023 · Expires Jun 15, 2043

    granted

  10. US 11643656

    Antisense therapies for treating cancer

    The United States Government represented by the Department of Veterans Affairs · Granted May 9, 2023 · Expires May 4, 2043

    granted

  11. US 11278521

    GAS5 binding compounds, formulations, and uses thereof

    THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS OFFICE OF GENERAL COUNSEL—PSG IV (024) · Granted Mar 22, 2022 · Expires Mar 17, 2042

    granted

  12. US 11274303

    Olmalinc as a diagnostic and therapeutic target for NAFLD, NASH, metabolic syndrome, and hepatic fibrosis

    The United States Government represented by the Department of Veterans Affairs · Granted Mar 15, 2022 · Expires Mar 10, 2042

    granted

  13. US 11253489

    Visual cycle modulators

    The United States Government as Represented by The Department of Veteran Affairs · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  14. US 11236139

    Combination immunotherapy

    The United States Government represented by the Department of Veterans Affairs · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted

  15. US 11186622

    PAC1 receptor agonists (MAXCAPS) and uses thereof

    The United States Government represented by the Department of Veterans Affairs · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted

  16. US 11129808

    PKC-delta-I inhibitor formulations and uses thereof

    THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERRANS AFFAIRS OFFICE OF THE GENERAL COUNSEL · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  17. US 11083801

    Factor VIII mutation repair and tolerance induction

    The United States Government Represented by the Departrment of Veteran Affairs · Granted Aug 10, 2021 · Expires Aug 5, 2041

    granted

  18. US 11053290

    Modified Tamm-Horsfall protein and related compositions and methods of use

    The United States Government as Represented by the Department of Veterans Affair · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted

  19. US 10961301

    Cell-penetrating anti-DNA antibodies and uses thereof inhibit DNA repair

    The United States Government represented by the Department of Veterans Affairs · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted

  20. US 10688063

    Treating and/or preventing insulin-resistance related weight gain

    The United States Government as Represented by the Department of Veterans Affairs of General Counsel- PSG IV (024) · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted

  21. US 10614684

    Treatment of kidney diseases associated with elevated AVP

    THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE · Granted Apr 7, 2020 · Expires Apr 2, 2040

    granted

  22. US 10583148

    Methods and devices for bone infection treatment selection

    The United States Government · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted

  23. US 10441642

    Immunogenic compositions and vaccines for preventing or treating filarial disease

    The United States Government, as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted

  24. US 10376495

    Small molecules that mimic or antagonize actions of granulocyte colony-stimulating-factor (G-CSF)

    The United States Government as Represented by the Department of Veterans · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.